Free Trial
→ Everyone’s watching Nvidia right now. Here’s why I’m excited. (From Timothy Sykes) (Ad) Buy NUVL Stock  Free NUVL Stock Alerts

Nuvalent (NUVL) Financials

Nuvalent logo
$73.49 +0.26 (+0.36%)
Closing price 05/23/2025 04:00 PM Eastern
Extended Trading
$73.52 +0.03 (+0.05%)
As of 05/23/2025 04:47 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare
Annual Income Statements for Nuvalent

Annual Income Statements for Nuvalent

This table shows Nuvalent's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2024 2023 2022 2021 2020
Period end date 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020
Net Income / (Loss) Attributable to Common Shareholders		 -261 -126 -82 -46 -15
Consolidated Net Income / (Loss)		 -261 -126 -82 -46 -15
Net Income / (Loss) Continuing Operations		 -261 -126 -82 -46 -15
Total Pre-Tax Income 		-260 -126 -82 -46 -15
Total Operating Income		 -280 -149 -86 -46 -17
Total Gross Profit		 0.00 0.00 0.00 0.00 0.00
Total Revenue		 0.00 0.00 0.00 0.00 0.00
Total Cost of Revenue		 0.00 0.00 0.00 0.00 0.00
Total Operating Expenses		 280 149 86 46 17
Selling, General & Admin Expense		 63 36 22 10 1.50
Research & Development Expense		 218 113 64 36 15
Total Other Income / (Expense), net		 20 23 4.25 -0.52 2.35
Income Tax Expense		 0.76 0.00 0.00 - -
Basic Earnings per Share		 ($3.93) ($2.17) ($1.65) ($2.13) ($5.08)
Weighted Average Basic Shares Outstanding		 66.41M 58.22M 49.67M 21.78M 2.87M
Diluted Earnings per Share		 ($3.93) ($2.17) ($1.65) ($2.13) ($5.08)
Weighted Average Diluted Shares Outstanding		 66.41M 58.22M 49.67M 21.78M 2.87M
Weighted Average Basic & Diluted Shares Outstanding		 71.60M 64.07M 56.70M 96.63M -

Quarterly Income Statements for Nuvalent

This table shows Nuvalent's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022
Period end date 3/31/2025 12/31/2024 9/30/2024 6/30/2024 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023 12/31/2022 9/30/2022
Net Income / (Loss) Attributable to Common Shareholders		 -85 -77 -81 -57 -44 -37 -33 -30 -25 -26 -20
Consolidated Net Income / (Loss)		 -85 -75 -84 -57 -44 -38 -34 -29 -25 -26 -20
Net Income / (Loss) Continuing Operations		 -85 -75 -84 -57 -44 -38 -34 -29 -25 -26 -20
Total Pre-Tax Income 		-84 -75 -84 -57 -44 -38 -34 -29 -25 -26 -20
Total Operating Income		 -95 -86 -76 -65 -53 -46 -39 -34 -30 -29 -20
Total Gross Profit		 0.00 - 0.00 0.00 0.00 - 0.00 0.00 0.00 - 0.00
Total Revenue		 0.00 - 0.00 0.00 0.00 - 0.00 0.00 0.00 - 0.00
Total Cost of Revenue		 0.00 - 0.00 0.00 0.00 - 0.00 0.00 0.00 - 0.00
Total Operating Expenses		 95 86 76 65 53 46 39 34 30 29 20
Selling, General & Admin Expense		 20 17 16 16 14 11 9.17 8.14 8.09 6.44 5.76
Research & Development Expense		 74 69 61 49 39 36 30 26 22 23 15
Total Other Income / (Expense), net		 10 12 -7.97 8.15 8.49 8.15 5.14 4.97 5.02 3.18 0.67
Income Tax Expense		 0.16 0.17 0.04 0.17 0.38 - 0.00 0.00 0.00 - -
Basic Earnings per Share		 ($1.18) ($1.08) ($1.28) ($0.88) ($0.69) ($0.63) ($0.59) ($0.51) ($0.44) ($0.50) ($0.41)
Weighted Average Basic Shares Outstanding		 71.61M 66.41M 65.68M 64.61M 64.15M 58.22M 57.09M 56.87M 56.70M 49.67M 48.41M
Diluted Earnings per Share		 ($1.18) ($1.08) ($1.28) ($0.88) ($0.69) ($0.63) ($0.59) ($0.51) ($0.44) ($0.50) ($0.41)
Weighted Average Diluted Shares Outstanding		 71.61M 66.41M 65.68M 64.61M 64.15M 58.22M 57.09M 56.87M 56.70M 49.67M 48.41M
Weighted Average Basic & Diluted Shares Outstanding		 71.81M 71.60M 71.05M 64.80M 64.56M 64.07M 62.63M 57.02M 56.82M 56.70M 56.44M

Annual Cash Flow Statements for Nuvalent

This table details how cash moves in and out of Nuvalent's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2024 2023 2022 2021 2020
Period end date 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020
Net Change in Cash & Equivalents		 -190 94 173 58 7.32
Net Cash From Operating Activities		 -185 -100 -65 -40 -15
Net Cash From Continuing Operating Activities		 -185 -100 -65 -40 -15
Net Income / (Loss) Continuing Operations		 -261 -126 -82 -46 -15
Consolidated Net Income / (Loss)		 -261 -126 -82 -46 -15
Amortization Expense		 -15 -10 -0.37 0.22 0.00
Non-Cash Adjustments To Reconcile Net Income		 79 26 10 4.18 -1.66
Changes in Operating Assets and Liabilities, net		 12 11 6.93 1.94 1.27
Net Cash From Investing Activities		 -574 -144 -11 -220 0.00
Net Cash From Continuing Investing Activities		 -574 -144 -11 -220 0.00
Purchase of Investments		 -1,025 -459 -213 -221 0.00
Sale and/or Maturity of Investments		 451 316 202 1.02 0.00
Net Cash From Financing Activities		 569 337 249 318 22
Net Cash From Continuing Financing Activities		 569 337 249 318 22
Repayment of Debt		 -0.62 0.00 -0.91 0.28 -0.25
Repurchase of Common Equity		 -0.48 -0.86 -0.64 -3.02 0.00
Issuance of Preferred Equity		 0.00 0.00 0.00 145 23
Issuance of Common Equity		 570 338 250 177 0.00
Other Financing Activities, net		 0.00 -0.78 0.00 -0.96 0.02

Quarterly Cash Flow Statements for Nuvalent

This table details how cash moves in and out of Nuvalent's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022
Period end date 3/31/2025 12/31/2024 9/30/2024 6/30/2024 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023 12/31/2022 9/30/2022
Net Change in Cash & Equivalents		 -25 -224 292 -21 -237 247 18 -19 -152 165 0.40
Net Cash From Operating Activities		 -55 -62 -46 -41 -36 -30 -23 -22 -24 -18 -18
Net Cash From Continuing Operating Activities		 -55 -62 -46 -41 -36 -30 -23 -22 -24 -18 -18
Net Income / (Loss) Continuing Operations		 -85 -75 -84 -57 -44 -38 -34 -29 -25 -26 -20
Consolidated Net Income / (Loss)		 -85 -75 -84 -57 -44 -38 -34 -29 -25 -26 -20
Amortization Expense		 -4.28 -4.93 -2.92 -3.43 -3.38 -2.09 -2.63 -2.85 -2.54 -0.83 -0.00
Non-Cash Adjustments To Reconcile Net Income		 22 17 32 15 14 7.49 6.85 5.85 5.37 3.02 2.65
Changes in Operating Assets and Liabilities, net		 12 0.22 9.39 4.31 -2.08 2.69 6.44 3.96 -2.06 6.16 -1.11
Net Cash From Investing Activities		 25 -170 -213 16 -207 -56 38 1.59 -127 -65 18
Net Cash From Continuing Investing Activities		 25 -170 -213 16 -207 -56 38 1.59 -127 -65 18
Purchase of Investments		 -277 -312 -341 -89 -283 -167 -23 -82 -188 -163 -20
Sale and/or Maturity of Investments		 303 142 128 105 76 110 62 83 61 97 37
Net Cash From Financing Activities		 4.55 8.49 550 4.14 5.99 333 2.14 1.30 -0.02 249 1.01
Net Cash From Continuing Financing Activities		 4.55 8.49 550 4.14 5.99 333 2.14 1.30 -0.02 249 1.01
Repurchase of Common Equity		 -0.01 -0.30 -0.19 - 0.00 -0.77 - - -0.09 -0.64 -
Issuance of Common Equity		 4.55 8.79 550 4.29 6.45 335 1.39 1.66 0.62 250 -
Other Financing Activities, net		 0.00 - - - - - - - - -0.61 0.39

Annual Balance Sheets for Nuvalent

This table presents Nuvalent's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2024 2023 2022 2021 2020
Period end date 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020
Total Assets		 1,142 732 482 294 11
Total Current Assets		 1,132 726 478 291 11
Cash & Equivalents		 146 335 242 69 10
Short-Term Investments		 973 385 230 220 0.00
Prepaid Expenses		 14 6.58 5.83 2.52 0.31
Plant, Property, & Equipment, net		 0.00 0.00 0.00 0.00 0.00
Total Noncurrent Assets		 9.30 5.90 4.47 3.20 0.00
Total Liabilities & Shareholders' Equity		 1,142 732 482 294 11
Total Liabilities		 72 32 19 8.79 6.62
Total Current Liabilities		 54 32 19 8.79 4.38
Accounts Payable		 5.23 9.27 7.20 2.89 1.25
Accrued Expenses		 49 23 12 5.89 1.17
Total Noncurrent Liabilities		 18 0.00 0.00 0.00 2.24
Other Noncurrent Operating Liabilities		 18 0.00 - - 2.24
Commitments & Contingencies		 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 1,070 701 463 285 -31
Total Preferred & Common Equity		 1,070 701 463 285 -31
Preferred Stock		 0.00 0.00 0.00 0.00 0.00
Total Common Equity		 1,070 701 463 285 -31
Common Stock		 1,617 987 624 363 0.84
Retained Earnings		 -547 -286 -160 -78 -32
Accumulated Other Comprehensive Income / (Loss)		 -0.06 0.03 -0.49 -0.23 0.00

Quarterly Balance Sheets for Nuvalent

This table presents Nuvalent's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q1 2025 Q3 2024 Q2 2024 Q1 2024 Q3 2023 Q2 2023 Q1 2023 Q3 2022
Period end date 3/31/2025 9/30/2024 6/30/2024 3/31/2024 9/30/2023 6/30/2023 3/31/2023 9/30/2022
Total Assets		 1,106 1,189 675 708 425 442 461 250
Total Current Assets		 1,087 1,180 666 699 420 437 456 245
Cash & Equivalents		 121 369 78 99 88 71 90 76
Short-Term Investments		 952 799 580 593 325 360 360 164
Prepaid Expenses		 13 11 8.26 7.66 6.52 5.75 5.83 5.18
Plant, Property, & Equipment, net		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Noncurrent Assets		 19 9.18 8.97 8.97 5.31 4.96 4.70 4.31
Total Liabilities & Shareholders' Equity		 1,106 1,189 675 708 425 442 461 250
Total Liabilities		 95 68 38 33 29 21 17 13
Total Current Liabilities		 75 51 38 33 29 21 17 13
Accounts Payable		 26 16 7.40 13 9.78 8.12 6.43 4.62
Accrued Expenses		 49 35 31 20 19 13 11 8.36
Total Noncurrent Liabilities		 20 17 0.00 0.00 0.00 0.00 0.00 0.00
Other Noncurrent Operating Liabilities		 20 17 - - - - - -
Commitments & Contingencies		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 1,011 1,121 637 675 396 421 444 237
Total Preferred & Common Equity		 1,011 1,121 637 675 396 421 444 237
Preferred Stock		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity		 1,011 1,121 637 675 396 421 444 237
Common Stock		 1,642 1,592 1,027 1,007 645 637 630 371
Retained Earnings		 -632 -472 -388 -331 -248 -214 -185 -134
Accumulated Other Comprehensive Income / (Loss)		 0.85 1.37 -1.57 -1.32 -1.31 -1.54 -0.30 -0.87

Annual Metrics And Ratios for Nuvalent

This table displays calculated financial ratios and metrics derived from Nuvalent's official financial filings.

Metric 2024 2023 2022 2021 2020
Period end date 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020
Growth Metrics		 - - - - -
Revenue Growth		 0.00% 0.00% 0.00% 0.00% 0.00%
EBITDA Growth		 -116.42% -65.79% -77.84% -217.65% 0.00%
EBIT Growth		 -122.13% -54.20% -76.21% -219.13% 0.00%
NOPAT Growth		 -87.55% -73.61% -87.94% -171.03% 0.00%
Net Income Growth		 -106.59% -54.20% -76.65% -218.34% 0.00%
EPS Growth		 -81.11% -31.52% 22.54% 58.07% 0.00%
Operating Cash Flow Growth		 -85.55% -53.51% -62.43% -167.58% 0.00%
Free Cash Flow Firm Growth		 -75.90% -75.94% -64.76% 0.00% 0.00%
Invested Capital Growth		 -129.06% -84.87% -117.75% 0.49% 0.00%
Revenue Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00%
EBITDA Q/Q Growth		 -16.92% 3.45% -11.85% 0.00% 0.00%
EBIT Q/Q Growth		 -16.57% 4.64% -10.33% 0.00% 0.00%
NOPAT Q/Q Growth		 -16.57% -12.95% -16.07% 0.00% 0.00%
Net Income Q/Q Growth		 -16.26% -10.67% -12.10% 0.00% 0.00%
EPS Q/Q Growth		 -12.93% -6.37% -166.53% 0.00% 0.00%
Operating Cash Flow Q/Q Growth		 -20.74% -14.24% -8.02% -25.07% 0.00%
Free Cash Flow Firm Q/Q Growth		 -13.86% -26.54% 0.00% 0.00% 0.00%
Invested Capital Q/Q Growth		 -22.53% -11.74% -292.21% 0.00% 0.00%
Profitability Metrics		 - - - - -
Gross Margin		 0.00% 0.00% 0.00% 0.00% 0.00%
EBITDA Margin		 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Margin		 0.00% 0.00% 0.00% 0.00% 0.00%
EBIT Margin		 0.00% 0.00% 0.00% 0.00% 0.00%
Profit (Net Income) Margin		 0.00% 0.00% 0.00% 0.00% 0.00%
Tax Burden Percent		 100.29% 100.00% 100.00% 100.00% 100.00%
Interest Burden Percent		 92.73% 100.00% 100.00% 99.75% 100.00%
Effective Tax Rate		 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)		 0.00% 0.00% 0.00% 0.00% 0.00%
ROIC Less NNEP Spread (ROIC-NNEP)		 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Net Nonoperating Assets (RNNOA)		 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Equity (ROE)		 -29.46% -21.70% -21.89% -32.06% -361.10%
Cash Return on Invested Capital (CROIC)		 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Return on Assets (OROA)		 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Assets (ROA)		 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Common Equity (ROCE)		 -29.46% -21.70% -21.89% -28.14% 2,805.95%
Return on Equity Simple (ROE_SIMPLE)		 -24.37% -18.02% -17.68% -16.26% 46.47%
Net Operating Profit after Tax (NOPAT)		 -196 -105 -60 -32 -12
NOPAT Margin		 0.00% 0.00% 0.00% 0.00% 0.00%
Net Nonoperating Expense Percent (NNEP)		 -6.96% -3.59% -5.62% -9.46% -26.35%
Return On Investment Capital (ROIC_SIMPLE)		 -18.35% -14.94% -13.02% - -
Cost of Revenue to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00%
SG&A Expenses to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00%
R&D to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings before Interest and Taxes (EBIT)		 -280 -126 -82 -46 -15
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 -295 -136 -82 -46 -15
Valuation Ratios		 - - - - -
Price to Book Value (P/BV)		 5.20 6.58 3.63 3.23 0.00
Price to Tangible Book Value (P/TBV)		 5.20 6.58 3.63 3.23 0.00
Price to Revenue (P/Rev)		 0.00 0.00 0.00 0.00 0.00
Price to Earnings (P/E)		 0.00 0.00 0.00 0.00 0.00
Dividend Yield		 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 0.00% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)		 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Revenue (EV/Rev)		 0.00 0.00 0.00 0.00 0.00
Enterprise Value to EBITDA (EV/EBITDA)		 0.00 0.00 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)		 0.00 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)		 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)		 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 0.00 0.00 0.00 0.00
Leverage & Solvency		 - - - - -
Debt to Equity		 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to Equity		 0.00 0.00 0.00 0.00 0.00
Financial Leverage		 -1.05 -1.03 -1.03 -1.04 -2.56
Leverage Ratio		 1.06 1.04 1.04 1.05 2.64
Compound Leverage Factor		 0.98 1.04 1.04 1.05 2.64
Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00%
Short-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00% 877.05%
Common Equity to Total Capital		 100.00% 100.00% 100.00% 100.00% -777.05%
Debt to EBITDA		 0.00 0.00 0.00 0.00 0.00
Net Debt to EBITDA		 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to EBITDA		 0.00 0.00 0.00 0.00 0.00
Debt to NOPAT		 0.00 0.00 0.00 0.00 0.00
Net Debt to NOPAT		 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to NOPAT		 0.00 0.00 0.00 0.00 0.00
Altman Z-Score		 46.03 86.92 51.88 63.03 5.72
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00% 12.23% 877.05%
Liquidity Ratios		 - - - - -
Current Ratio		 20.96 22.83 24.54 33.07 2.43
Quick Ratio		 20.70 22.62 24.24 32.79 2.36
Cash Flow Metrics		 - - - - -
Free Cash Flow to Firm (FCFF)		 -164 -93 -53 -32 0.00
Operating Cash Flow to CapEx		 0.00% 0.00% 0.00% 0.00% 0.00%
Free Cash Flow to Firm to Interest Expense		 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense		 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios		 - - - - -
Asset Turnover		 0.00 0.00 0.00 0.00 0.00
Accounts Receivable Turnover		 0.00 0.00 0.00 0.00 0.00
Inventory Turnover		 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover		 0.00 0.00 0.00 0.00 0.00
Accounts Payable Turnover		 0.00 0.00 0.00 0.00 0.00
Days Sales Outstanding (DSO)		 0.00 0.00 0.00 0.00 0.00
Days Inventory Outstanding (DIO)		 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)		 0.00 0.00 0.00 0.00 0.00
Cash Conversion Cycle (CCC)		 0.00 0.00 0.00 0.00 0.00
Capital & Investment Metrics		 - - - - -
Invested Capital		 -58 -25 -14 -6.27 -6.30
Invested Capital Turnover		 0.00 0.00 0.00 0.00 0.00
Increase / (Decrease) in Invested Capital		 -33 -12 -7.38 0.03 0.00
Enterprise Value (EV)		 4,444 3,889 1,209 631 176
Market Capitalization		 5,562 4,609 1,681 919 151
Book Value per Share		 $15.06 $11.19 $8.20 $5.90 ($10.92)
Tangible Book Value per Share		 $15.06 $11.19 $8.20 $5.90 ($10.92)
Total Capital		 1,070 701 463 285 4.03
Total Debt		 0.00 0.00 0.00 0.00 0.00
Total Long-Term Debt		 0.00 0.00 0.00 0.00 0.00
Net Debt		 -1,118 -720 -472 -288 -10
Capital Expenditures (CapEx)		 0.00 0.00 0.00 0.00 0.00
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 -40 -25 -14 -6.27 -4.07
Debt-free Net Working Capital (DFNWC)		 1,078 695 459 282 6.27
Net Working Capital (NWC)		 1,078 695 459 282 6.27
Net Nonoperating Expense (NNE)		 64 22 22 14 2.72
Net Nonoperating Obligations (NNO)		 -1,128 -726 -477 -291 -10
Total Depreciation and Amortization (D&A)		 -15 -10 -0.37 0.22 0.00
Debt-free, Cash-free Net Working Capital to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00%
Debt-free Net Working Capital to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00%
Net Working Capital to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Adjustments		 - - - - -
Adjusted Basic Earnings per Share		 ($3.93) ($2.17) ($1.65) ($2.13) $0.00
Adjusted Weighted Average Basic Shares Outstanding		 66.41M 58.22M 49.67M 21.78M 0.00
Adjusted Diluted Earnings per Share		 ($3.93) ($2.17) ($1.65) ($2.13) $0.00
Adjusted Weighted Average Diluted Shares Outstanding		 66.41M 58.22M 49.67M 21.78M 0.00
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 71.60M 64.07M 56.70M 96.63M 0.00
Normalized Net Operating Profit after Tax (NOPAT)		 -196 -105 -60 -32 -12
Normalized NOPAT Margin		 0.00% 0.00% 0.00% 0.00% 0.00%
Pre Tax Income Margin		 0.00% 0.00% 0.00% 0.00% 0.00%
Debt Service Ratios		 - - - - -
EBIT to Interest Expense		 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense		 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00
Payout Ratios		 - - - - -
Dividend Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio		 -0.19% -0.68% -0.79% -6.52% 0.00%

Quarterly Metrics And Ratios for Nuvalent

This table displays calculated financial ratios and metrics derived from Nuvalent's official financial filings.

Metric Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022
Period end date 3/31/2025 12/31/2024 9/30/2024 6/30/2024 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023 12/31/2022 9/30/2022
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EBITDA Growth		 -108.70% -87.99% -91.37% -85.81% -70.91% -61.05% -103.09% -99.02% -88.08% -75.30% -64.11%
EBIT Growth		 -115.00% -85.84% -96.82% -91.27% -74.07% -58.49% -90.22% -81.83% -70.79% -68.36% -64.08%
NOPAT Growth		 -80.29% -85.84% -96.82% -91.27% -74.07% -58.49% -90.22% -81.83% -70.79% -68.60% -64.06%
Net Income Growth		 -90.15% -95.24% -150.69% -96.51% -76.57% -46.58% -70.65% -57.53% -43.55% -51.10% -58.67%
EPS Growth		 -71.01% -71.43% -116.95% -72.55% -56.82% -26.00% -43.90% -34.21% -22.22% -113.77% -5.13%
Operating Cash Flow Growth		 -51.91% -105.24% -99.37% -85.95% -47.81% -69.91% -26.44% -43.04% -80.28% -37.24% -59.43%
Free Cash Flow Firm Growth		 51.79% -33.06% -258.62% -140.36% -61.38% -59.37% 33.48% -23.12% -60.89% 0.00% -63.34%
Invested Capital Growth		 -215.95% -129.06% -108.89% -98.96% -130.29% -84.87% -548.89% -278.03% -193.01% -117.75% -168.18%
Revenue Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EBITDA Q/Q Growth		 -8.62% -15.12% -15.56% -22.54% -15.33% -17.18% -12.20% -12.71% -8.68% -47.77% -9.95%
EBIT Q/Q Growth		 -9.86% -13.06% -17.16% -23.89% -13.25% -19.74% -13.86% -12.75% -3.11% -43.71% -8.83%
NOPAT Q/Q Growth		 -9.86% -13.06% -17.16% -23.89% -13.25% -19.74% -13.86% -12.75% -3.11% -43.71% -8.83%
Net Income Q/Q Growth		 -13.13% 11.36% -47.54% -28.51% -16.17% -13.81% -15.66% -15.47% 3.56% -32.50% -6.77%
EPS Q/Q Growth		 -9.26% 15.63% -45.45% -27.54% -9.52% -6.78% -15.69% -15.91% 12.00% -21.95% -7.89%
Operating Cash Flow Q/Q Growth		 11.58% -35.32% -11.31% -14.06% -19.46% -31.45% -3.82% 9.33% -37.32% 2.18% -17.45%
Free Cash Flow Firm Q/Q Growth		 61.50% 3.47% 6.13% -38.18% -6.28% -160.15% 37.08% 7.23% -4.95% -8.58% -16.46%
Invested Capital Q/Q Growth		 -40.83% -22.53% -57.66% -16.14% -2.10% -11.74% -50.17% -34.42% 18.04% -292.21% 12.52%
Profitability Metrics		 - - - - - - - - - - -
Gross Margin		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EBITDA Margin		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Margin		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EBIT Margin		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Profit (Net Income) Margin		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Tax Burden Percent		 100.19% 100.23% 100.05% 100.30% 100.87% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
Interest Burden Percent		 89.04% 86.43% 110.45% 87.48% 83.86% 82.46% 86.75% 85.40% 83.39% 89.16% 96.70%
Effective Tax Rate		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
ROIC Less NNEP Spread (ROIC-NNEP)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Net Nonoperating Assets (RNNOA)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Equity (ROE)		 -35.69% -29.46% -29.57% -32.81% -26.01% -21.70% -36.06% -29.70% -25.11% -21.89% -27.16%
Cash Return on Invested Capital (CROIC)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Return on Assets (OROA)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Assets (ROA)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Common Equity (ROCE)		 -35.69% -29.46% -29.57% -32.81% -26.01% -21.70% -36.06% -29.70% -25.11% -21.89% -27.16%
Return on Equity Simple (ROE_SIMPLE)		 -29.76% 0.00% -20.01% -27.25% -21.56% 0.00% -28.80% -23.77% -20.16% 0.00% -30.86%
Net Operating Profit after Tax (NOPAT)		 -66 -60 -53 -46 -37 -33 -27 -24 -21 -21 -14
NOPAT Margin		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Nonoperating Expense Percent (NNEP)		 -2.03% -1.55% -3.90% -2.10% -1.33% -0.96% -1.97% -1.51% -1.11% -1.46% -2.01%
Return On Investment Capital (ROIC_SIMPLE)		 -6.56% -5.65% - - - -4.64% - - - -4.43% -
Cost of Revenue to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
SG&A Expenses to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
R&D to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings before Interest and Taxes (EBIT)		 -95 -86 -76 -65 -53 -46 -39 -34 -30 -29 -20
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 -99 -91 -79 -69 -56 -49 -41 -37 -33 -30 -20
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 5.02 5.20 5.91 7.69 6.97 6.58 6.62 5.69 3.33 3.63 3.98
Price to Tangible Book Value (P/TBV)		 5.02 5.20 5.91 7.69 6.97 6.58 6.62 5.69 3.33 3.63 3.98
Price to Revenue (P/Rev)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Price to Earnings (P/E)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Revenue (EV/Rev)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to EBITDA (EV/EBITDA)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to Equity		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Financial Leverage		 -1.06 -1.05 -1.05 -1.04 -1.03 -1.03 -1.04 -1.03 -1.02 -1.03 -1.01
Leverage Ratio		 1.08 1.06 1.06 1.06 1.05 1.04 1.07 1.05 1.04 1.04 1.04
Compound Leverage Factor		 0.96 0.92 1.18 0.92 0.88 0.86 0.93 0.89 0.86 0.93 1.00
Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Short-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
Debt to EBITDA		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt to EBITDA		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to EBITDA		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Debt to NOPAT		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt to NOPAT		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to NOPAT		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Altman Z-Score		 32.17 46.59 59.09 76.93 84.64 87.28 54.03 69.33 52.52 52.24 43.62
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios		 - - - - - - - - - - -
Current Ratio		 14.48 20.96 23.07 17.45 20.93 22.83 14.42 21.01 26.81 24.54 18.90
Quick Ratio		 14.30 20.70 22.85 17.23 20.70 22.62 14.20 20.74 26.47 24.24 18.50
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 -11 -28 -29 -31 -22 -21 -8.04 -13 -14 -13 -12
Operating Cash Flow to CapEx		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Free Cash Flow to Firm to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Accounts Receivable Turnover		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Inventory Turnover		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Accounts Payable Turnover		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Sales Outstanding (DSO)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Inventory Outstanding (DIO)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Cash Conversion Cycle (CCC)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 -81 -58 -47 -30 -26 -25 -23 -15 -11 -14 -3.48
Invested Capital Turnover		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Increase / (Decrease) in Invested Capital		 -56 -33 -25 -15 -15 -12 -19 -11 -7.37 -7.38 -2.18
Enterprise Value (EV)		 4,004 4,444 5,460 4,239 4,011 3,889 2,208 1,965 1,029 1,209 701
Market Capitalization		 5,078 5,562 6,629 4,897 4,703 4,609 2,621 2,396 1,479 1,681 941
Book Value per Share		 $14.12 $15.06 $17.30 $9.87 $10.52 $11.19 $6.94 $7.41 $7.83 $8.20 $4.89
Tangible Book Value per Share		 $14.12 $15.06 $17.30 $9.87 $10.52 $11.19 $6.94 $7.41 $7.83 $8.20 $4.89
Total Capital		 1,011 1,070 1,121 637 675 701 396 421 444 463 237
Total Debt		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Long-Term Debt		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt		 -1,073 -1,118 -1,168 -658 -692 -720 -413 -431 -450 -472 -240
Capital Expenditures (CapEx)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 -62 -40 -40 -30 -26 -25 -23 -15 -11 -14 -7.79
Debt-free Net Working Capital (DFNWC)		 1,012 1,078 1,129 628 666 695 391 416 439 459 232
Net Working Capital (NWC)		 1,012 1,078 1,129 628 666 695 391 416 439 459 232
Net Nonoperating Expense (NNE)		 18 14 31 12 7.67 5.79 6.50 5.25 4.05 5.61 5.44
Net Nonoperating Obligations (NNO)		 -1,092 -1,128 -1,168 -667 -701 -726 -419 -436 -455 -477 -240
Total Depreciation and Amortization (D&A)		 -4.28 -4.93 -2.92 -3.43 -3.38 -2.09 -2.63 -2.85 -2.54 -0.83 -0.00
Debt-free, Cash-free Net Working Capital to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Debt-free Net Working Capital to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Working Capital to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 ($1.18) ($1.08) ($1.28) ($0.88) ($0.69) ($0.63) ($0.59) ($0.51) ($0.44) ($0.50) ($0.41)
Adjusted Weighted Average Basic Shares Outstanding		 71.61M 66.41M 65.68M 64.61M 64.15M 58.22M 57.09M 56.87M 56.70M 49.67M 48.41M
Adjusted Diluted Earnings per Share		 ($1.18) ($1.08) ($1.28) ($0.88) ($0.69) ($0.63) ($0.59) ($0.51) ($0.44) ($0.50) ($0.41)
Adjusted Weighted Average Diluted Shares Outstanding		 71.61M 66.41M 65.68M 64.61M 64.15M 58.22M 57.09M 56.87M 56.70M 49.67M 48.41M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 71.81M 71.60M 71.05M 64.80M 64.56M 64.07M 62.63M 57.02M 56.82M 56.70M 56.44M
Normalized Net Operating Profit after Tax (NOPAT)		 -66 -60 -53 -46 -37 -33 -27 -24 -21 -21 -14
Normalized NOPAT Margin		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Pre Tax Income Margin		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio		 -0.16% -0.19% -0.43% -0.44% -0.53% -0.68% -0.64% -0.73% -0.82% -0.79% -0.51%

Frequently Asked Questions About Nuvalent's Financials

When does Nuvalent's fiscal year end?

According to the most recent income statement we have on file, Nuvalent's financial year ends in December. Their financial year 2024 ended on December 31, 2024.

How has Nuvalent's net income changed over the last 4 years?

Nuvalent's net income appears to be on an upward trend, with a most recent value of -$260.76 million in 2024, rising from -$14.56 million in 2020. The previous period was -$126.22 million in 2023. Find out what analysts predict for Nuvalent in the coming months.

What is Nuvalent's operating income?
Nuvalent's total operating income in 2024 was -$280.37 million, based on the following breakdown:
  • Total Gross Profit: $0.00
  • Total Operating Expenses: $280.37 million
How has Nuvalent revenue changed over the last 4 years?

Over the last 4 years, Nuvalent's total revenue changed from $0.00 in 2020 to $0.00 in 2024, a change of 0.0%.

How much debt does Nuvalent have?

Nuvalent's total liabilities were at $71.96 million at the end of 2024, a 126.1% increase from 2023, and a 987.8% increase since 2020.

How much cash does Nuvalent have?

In the past 4 years, Nuvalent's cash and equivalents has ranged from $10.33 million in 2020 to $335.39 million in 2023, and is currently $145.69 million as of their latest financial filing in 2024.

How has Nuvalent's book value per share changed over the last 4 years?

Over the last 4 years, Nuvalent's book value per share changed from -10.92 in 2020 to 15.06 in 2024, a change of -237.8%.


Related Companies

This page (NASDAQ:NUVL) was last updated on 5/25/2025 by MarketBeat.com Staff
From Our Partners
Gold Hits New Highs as Global Markets Spiral
When Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...
Premier Gold Co | Sponsored
White House to reset Social Security?
Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...
Altimetry | Sponsored
Buffett’s favorite chart just hit 209% – here’s what that means for gold
A Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...
Golden Portfolio | Sponsored
Is President Trump Lying To You With This?
President Trump’s economic transition isn’t without hardship. But what if there were a smart, tax-free way to ...
Colonial Metals | Sponsored
A grave, grave error.
I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...
Porter & Company | Sponsored
Trump’s Bitcoin Reserve is No Accident…
Bitcoin's supply is being drained at unprecedented rates, but while most investors focus solely on Bitcoin, th...
Crypto 101 Media | Sponsored
Massive new energy source found in Utah
NEW THIS WEEK: Huge Energy Discovery In Utah The Department of Energy say it could power America for millio...
Stansberry Research | Sponsored
Elon Set to Shock the World on June 1st?
Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...
Brownstone Research | Sponsored